150 related articles for article (PubMed ID: 27820679)
1. Malathion dermal permeability in relation to dermal load: Assessment by physiologically based pharmacokinetic modeling of in vivo human data.
Bogen KT; Singhal A
J Environ Sci Health B; 2017 Feb; 52(2):138-146. PubMed ID: 27820679
[TBL] [Abstract][Full Text] [Related]
2. A toxicokinetic model of malathion and its metabolites as a tool to assess human exposure and risk through measurements of urinary biomarkers.
Bouchard M; Gosselin NH; Brunet RC; Samuel O; Dumoulin MJ; Carrier G
Toxicol Sci; 2003 May; 73(1):182-94. PubMed ID: 12657741
[TBL] [Abstract][Full Text] [Related]
3. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
[TBL] [Abstract][Full Text] [Related]
4. A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds.
Roy A; Weisel CP; Lioy PJ; Georgopoulos PG
Risk Anal; 1996 Apr; 16(2):147-60. PubMed ID: 8638037
[TBL] [Abstract][Full Text] [Related]
5. Utility of real time breath analysis and physiologically based pharmacokinetic modeling to determine the percutaneous absorption of methyl chloroform in rats and humans.
Poet TS; Thrall KD; Corley RA; Hui X; Edwards JA; Weitz KK; Maibach HI; Wester RC
Toxicol Sci; 2000 Mar; 54(1):42-51. PubMed ID: 10746930
[TBL] [Abstract][Full Text] [Related]
6. New experimental data on the human dermal absorption of Simazine and Carbendazim help to refine the assessment of human exposure.
Bányiová K; Nečasová A; Kohoutek J; Justan I; Čupr P
Chemosphere; 2016 Feb; 145():148-56. PubMed ID: 26688251
[TBL] [Abstract][Full Text] [Related]
7. Use of real-time breath analysis and physiologically based pharmacokinetic modeling to evaluate dermal absorption of aqueous toluene in human volunteers.
Thrall KD; Weitz KK; Woodstock AD
Toxicol Sci; 2002 Aug; 68(2):280-7. PubMed ID: 12151623
[TBL] [Abstract][Full Text] [Related]
8. Development of a human physiologically based pharmacokinetic (PBPK) model for dermal permeability for lindane.
Sawyer ME; Evans MV; Wilson CA; Beesley LJ; Leon LS; Eklund CR; Croom EL; Pegram RA
Toxicol Lett; 2016 Mar; 245():106-9. PubMed ID: 26794662
[TBL] [Abstract][Full Text] [Related]
9. The usual suspects-influence of physicochemical properties on lag time, skin deposition, and percutaneous penetration of nine model compounds.
Bo Nielsen J; Ahm Sørensen J; Nielsen F
J Toxicol Environ Health A; 2009; 72(5):315-23. PubMed ID: 19184747
[TBL] [Abstract][Full Text] [Related]
10. Effect of PBPK model structure on interpretation of in vivo human aqueous dermal exposure trials.
Norman AM; Kissel JC; Shirai JH; Smith JA; Stumbaugh KL; Bunge AL
Toxicol Sci; 2008 Jul; 104(1):210-7. PubMed ID: 18381354
[TBL] [Abstract][Full Text] [Related]
11. The implications of using a physiologically based pharmacokinetic (PBPK) model for pesticide risk assessment.
Lu C; Holbrook CM; Andres LM
Environ Health Perspect; 2010 Jan; 118(1):125-30. PubMed ID: 20056589
[TBL] [Abstract][Full Text] [Related]
12. PBPK modeling of the percutaneous absorption of perchloroethylene from a soil matrix in rats and humans.
Poet TS; Weitz KK; Gies RA; Edwards JA; Thrall KD; Corley RA; Tanojo H; Hui X; Maibach HI; Wester RC
Toxicol Sci; 2002 May; 67(1):17-31. PubMed ID: 11961212
[TBL] [Abstract][Full Text] [Related]
13. Estimation of dermal absorption using the exponential saturation model.
Thongsinthusak T; Ross JH; Saiz SG; Krieger RI
Regul Toxicol Pharmacol; 1999 Feb; 29(1):37-43. PubMed ID: 10051417
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the percutaneous absorption of trichloroethylene in rats and humans using MS/MS real-time breath analysis and physiologically based pharmacokinetic modeling.
Poet TS; Corley RA; Thrall KD; Edwards JA; Tanojo H; Weitz KK; Hui X; Maibach HI; Wester RC
Toxicol Sci; 2000 Jul; 56(1):61-72. PubMed ID: 10869454
[TBL] [Abstract][Full Text] [Related]
15. Hydroquinone PBPK model refinement and application to dermal exposure.
Poet TS; Carlton BD; Deyo JA; Hinderliter PM
Food Chem Toxicol; 2010 Nov; 48(11):3085-92. PubMed ID: 20692312
[TBL] [Abstract][Full Text] [Related]
16. Chemomorphic analysis of malathion in skin layers of the rat: implications for the use of dermatopharmacokinetic tape stripping in exposure assessment to pesticides.
Dary CC; Blancato JN; Saleh MA
Regul Toxicol Pharmacol; 2001 Dec; 34(3):234-48. PubMed ID: 11754528
[TBL] [Abstract][Full Text] [Related]
17. Linking a PBPK model for chloroform with measured breath concentrations in showers: implications for dermal exposure models.
McKone TE
J Expo Anal Environ Epidemiol; 1993; 3(3):339-65. PubMed ID: 8260842
[TBL] [Abstract][Full Text] [Related]
18. Malathion percutaneous absorption after repeated administration to man.
Wester RC; Maibach HI; Bucks DA; Guy RH
Toxicol Appl Pharmacol; 1983 Mar; 68(1):116-9. PubMed ID: 6845371
[TBL] [Abstract][Full Text] [Related]
19. NTP-CERHR monograph on the potential human reproductive and developmental effects of acrylamide.
National Toxicology Program
NTP CERHR MON; 2005 Feb; (14):v-I-2, II-xi-166, III-1-74. PubMed ID: 15995732
[TBL] [Abstract][Full Text] [Related]
20. In vitro dermal absorption rate testing of certain chemicals of interest to the Occupational Safety and Health Administration: summary and evaluation of USEPA's mandated testing.
Fasano WJ; McDougal JN
Regul Toxicol Pharmacol; 2008 Jul; 51(2):181-94. PubMed ID: 18501488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
